OBJECTIVES: In 2011 was published 12.401 Law establishing the National Committee for Technologies Incorporation in SUS (CONITEC) and defining the criteria and deadlines for the analysis and adoption of technologies. According to the law, CONITEC’s assessment must considers necessarily scientific evidences about efficacy, accuracy, effectiveness and safety of technologies and economic evaluation studies of benefits and costs in relation to the technologies already incorporated in SUS. Studies of economic evaluation traditionally ignore equity in health, and because this gap, researches have been undertaken to develop methods to incorporate equity into economic evaluation in health. Thus, this paper aims to analyze the viability of using an economic evaluation framework in the decision making process about incorporating technologies so that the equity is maximized within the Brazilian Unified Health System. METHODS: To fulfill this goal, review the scientific literature for methods to incorporate equity into cost-effectiveness was conducted with subsequent discussion how the methods found can be applied in the context of SUS, a system that offers universal coverage to approximately 201 million citizens. RESULTS: Until end of 2013, CONITEC recommended the incorporation of 64 technologies for diagnosis, prevention and treatment of various diseases, and no study of economic evaluation submitted addressed the issue of equity. By the research found a systematic review conducted by Johri & Norheim (2012) having found three distinct approaches: integration of distributional concerns through equity weights and social welfare functions, exploration of the opportunity costs of alternative policy options, through mathematical programming and multi-criteria decision analysis. CONCLUSIONS: These and other methods may be used by CONITEC’s assessment, approaching the issues of efficiency and equity in decision making. Thus, is expected to contribute to the development and application of these decision-support tools and to improve the criteria of Ministry of Health for deciding which technologies to fund.